{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:23:18Z","timestamp":1786112598035,"version":"build-2736575974"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1097\/01.icu.0000247411.59213.bb","type":"journal-article","created":{"date-parts":[[2006,10,25]],"date-time":"2006-10-25T05:20:36Z","timestamp":1161753636000},"page":"551-556","source":"Crossref","is-referenced-by-count":34,"title":["Beh\u00e7et's disease: general concepts and recent advances"],"prefix":"10.1097","volume":"17","author":[{"given":"Annabelle A","family":"Okada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210206","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Beh\u00e7et's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"R2-12-20210206","first-page":"225","article-title":"Beh\u00e7et's disease in Japan: ophthalmologic aspects","volume":"77","author":"Mishima","year":"1979","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R3-12-20210206","first-page":"820","article-title":"The prevalence of Beh\u00e7et's syndrome in a rural area in northern Turkey","volume":"15","author":"Yurdakul","year":"1988","journal-title":"J Rheumatol"},{"key":"R4-12-20210206","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3349\/ymj.1997.38.6.411","article-title":"Epidemiological features of Adamantiades-Beh\u00e7et's disease in Germany and in Europe","volume":"38","author":"Zouboulis","year":"1997","journal-title":"Yonsei Med J"},{"key":"R5-12-20210206","first-page":"145","article-title":"Recent epidemiologic features of Beh\u00e7et's disease in Japan","author":"Nakae","year":"1993"},{"key":"R6-12-20210206","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2003.07.018","article-title":"Comparison of patients with Beh\u00e7et's disease in the 1980s and 1990s","volume":"111","author":"Yoshida","year":"2004","journal-title":"Ophthalmology"},{"key":"R7-12-20210206","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/ard.43.6.783","article-title":"Influence of age of onset and patient's sex on the prevalence and severity of Beh\u00e7et's syndrome","volume":"43","author":"Yazici","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"R8-12-20210206","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0161-6420(95)31022-6","article-title":"Prognostic factors of vision in patients with Beh\u00e7et disease","volume":"102","author":"Akamoto","year":"1995","journal-title":"Ophthalmology"},{"key":"R9-12-20210206","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Beh\u00e7et's disease: an analysis of 880 patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R10-12-20210206","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0002-9394(14)71396-0","article-title":"Beh\u00e7et's disease associated with one of the HLA-B51 subantigens, HLA-B*5101","volume":"116","author":"Mizuki","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"R12-12-20210206","first-page":"11","article-title":"Studies of HLA antigens in Beh\u00e7et disease in Japan","author":"Ohno","year":"1986"},{"key":"R14-12-20210206","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/08830189709116846","article-title":"Vasculitis in Beh\u00e7et's disease","volume":"14","author":"Ehrlich","year":"1997","journal-title":"Int Rev Immunol"},{"key":"R15-12-20210206","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2230.2004.01488.x","article-title":"Erythrocyte superoxide dismutase, catalase activities and plasma nitrite and nitrate levels in patients with Beh\u00e7et's disease and recurrent aphthous stomatitis","volume":"29","author":"Gunduz","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"R16-12-20210206","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2133.2004.06003.x","article-title":"Increased advanced oxidation protein products in Beh\u00e7et's disease: a new activity marker?","volume":"151","author":"Yazici","year":"2004","journal-title":"Br J Dermatol"},{"key":"R17-12-20210206","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2249.1997.3611265.x","article-title":"Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Beh\u00e7et's disease (BD) in Japan","volume":"108","author":"Kaneko","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"R18-12-20210206","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1365-3083.1996.d01-53.x","article-title":"Recognition of B-cell epitopes of the 65 kDa HSP in Beh\u00e7et's disease","volume":"43","author":"Direskeneli","year":"1996","journal-title":"Scand J Immunol"},{"key":"R19-12-20210206","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/08830189709116842","article-title":"The role of heat shock protein, microbial and autoimmune agents in the aetiology of Beh\u00e7et's disease","volume":"14","author":"Lehner","year":"1997","journal-title":"Int Rev Immunol"},{"key":"R20-12-20210206","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/1529-0131(199909)42:9<1967::AID-ANR24>3.0.CO;2-Z","article-title":"Th1 polarization of the immune response in Beh\u00e7et's disease: a putative pathogenic role of interleukin-12","volume":"42","author":"Franssanito","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R22-12-20210206","doi-asserted-by":"crossref","first-page":"596","DOI":"10.47102\/annals-acadmedsg.V33N5p596","article-title":"Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Beh\u00e7et's disease","volume":"33","author":"Akdeniz","year":"2004","journal-title":"Ann Acad Med Singapore"},{"key":"R23-12-20210206","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1076\/ocii.12.1.53.28062","article-title":"The demonstration of serum interleukin 6\u20138, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Beh\u00e7et's disease with ocular involvement","volume":"12","author":"Bardak","year":"2004","journal-title":"Ocular Immunol Inflamm"},{"key":"R24-12-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00296-003-0400-6","article-title":"Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Beh\u00e7et's disease","volume":"25","author":"D\u00fczg\u00fcn","year":"2005","journal-title":"Rheumatol Int"},{"key":"R25-12-20210206","first-page":"S17","article-title":"Serum soluble CD30 levels in Beh\u00e7et's disease","volume":"22","author":"D\u00fczg\u00fcn","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R26-12-20210206","first-page":"93","article-title":"Polymorphisms of the IL-8 and CXCR2 genes are not associated with Beh\u00e7et's disease","volume":"32","author":"Duymaz-Tozkir","year":"2005","journal-title":"J Rheumatol"},{"key":"R27-12-20210206","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2249.2004.02688.x","article-title":"Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Beh\u00e7et's disease","volume":"139","author":"Nagafuchi","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"R28-12-20210206","first-page":"287","article-title":"Serum mannose-binding lectin levels are decreased in Beh\u00e7et's disease and associated with disease severity","volume":"32","author":"Inanc","year":"2005","journal-title":"J Rheumatol"},{"key":"R29-12-20210206","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaut.2004.07.005","article-title":"Abnormal expression of chemokine receptors in Beh\u00e7et's disease: relationship to intracellular Th1\/Th2 cytokines and to clinical manifestations","volume":"23","author":"Houman","year":"2004","journal-title":"J Autoimmun"},{"key":"R30-12-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08830189709116840","article-title":"The place of Beh\u00e7et's syndrome among the autoimmune diseases","volume":"14","author":"Yazici","year":"1997","journal-title":"Intern Rev Immunol"},{"key":"R32-12-20210206","first-page":"S59","article-title":"T and NK cell subset changes with microbial extracts and human SHP60-derived peptides in Beh\u00e7et's disease","volume":"22","author":"Kibaroglu","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R33-12-20210206","first-page":"133","article-title":"Beh\u00e7et's disease in patients of German and Turkish origin living in Germany: a comparative analysis","volume":"31","author":"K\u00f6tter","year":"2004","journal-title":"J Rheumatol"},{"key":"R34-12-20210206","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10384-003-0024-0","article-title":"Color Doppler imaging of ocular hemodynamic changes in Beh\u00e7et's disease","volume":"48","author":"\u00c7a\u00e7a","year":"2004","journal-title":"Jpn J Ophthalmology"},{"key":"R35-12-20210206","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.amjcard.2004.04.073","article-title":"Vascular endothelial function and plasma homocysteine levels in Behcet's disease","volume":"94","author":"Ozdemir","year":"2004","journal-title":"Am J Cardiol"},{"key":"R36-12-20210206","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00296-003-0398-9","article-title":"Serum homocysteine level is higher in Beh\u00e7et's disease with vascular involvement","volume":"25","author":"Ates","year":"2005","journal-title":"Rheumatol Int"},{"key":"R37-12-20210206","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ajo.2003.12.010","article-title":"Endothelial cell activation and hypercoagulability in ocular Beh\u00e7et's disease","volume":"137","author":"Probst","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R38-12-20210206","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.thromres.2004.09.010","article-title":"Thrombin activatable fibrinolysis inhibitor in Beh\u00e7et's disease","volume":"115","author":"Donmez","year":"2005","journal-title":"Thrombosis Res"},{"key":"R39-12-20210206","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1136\/ard.2003.014241","article-title":"Thrombophilic factors are not the leading cause of thrombosis in Beh\u00e7et's disease","volume":"63","author":"Leiba","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R40-12-20210206","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/keh561","article-title":"Polymorphisms in the endothelial nitric oxide synthase gene are associated with Beh\u00e7et's disease","volume":"44","author":"Karasneh","year":"2005","journal-title":"Rheumatology"},{"key":"R41-12-20210206","first-page":"291","article-title":"Behcets disease: guide to diagnosis of Behcets disease [editorial].","volume":"18","year":"1974","journal-title":"Jpn J Ophthalmol"},{"key":"R42-12-20210206","first-page":"1078","article-title":"Criteria for diagnosis of Behcets disease.","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"R44-12-20210206","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00061198-200412000-00002","article-title":"Incidence of secondary glaucoma in Beh\u00e7et disease","volume":"13","author":"Elgin","year":"2004","journal-title":"J Glaucoma"},{"key":"R45-12-20210206","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1076\/0927-3948(200006)821-0FT085","article-title":"Drug therapy in Beh\u00e7et's disease","volume":"8","author":"Okada","year":"2000","journal-title":"Ocular Immunol Inflamm"},{"key":"R46-12-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09273940590951034","article-title":"Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature","volume":"13","author":"Okada","year":"2005","journal-title":"Ocular Immunol Inflamm"},{"key":"R47-12-20210206","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.survophthal.2005.04.009","article-title":"Current concepts in the etiology and treatment of Beh\u00e7et's disease","volume":"50","author":"Evereklioglu","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"R49-12-20210206","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Beh\u00e7et's syndrome","volume":"322","author":"Yacizi","year":"1990","journal-title":"N Engl J Med"},{"key":"R50-12-20210206","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/rheumatology\/keg453","article-title":"The Beh\u00e7et's disease activity index","volume":"43","author":"Lawton","year":"2004","journal-title":"Rheumatology"},{"key":"R51-12-20210206","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ophtha.2004.12.034","article-title":"Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis","volume":"112","author":"Nussenblatt","year":"2005","journal-title":"Ophthalmology"},{"key":"R52-12-20210206","doi-asserted-by":"crossref","first-page":"404","DOI":"10.7326\/0003-4819-140-5-200403020-00025","article-title":"Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Beh\u00e7et disease","volume":"140","author":"Sfkakis","year":"2004","journal-title":"Ann Intern Med"},{"issue":"Suppl 34","key":"R53-12-20210206","first-page":"S14","article-title":"Infliximab in refractory uveitis due to Beh\u00e7et's disease","volume":"22","author":"Weschler","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"R54-12-20210206","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/112067210401400515","article-title":"Infliximab for the treatment of posterior uveitis with retinal neovascularization in Beh\u00e7et disease","volume":"4","author":"Giansanti","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"R55-12-20210206","first-page":"185","article-title":"The treatment of recurrent uveitis with TNF\u03b1 inhibitors","volume":"56","author":"Falappone","year":"2004","journal-title":"Reumatismo"},{"key":"R56-12-20210206","first-page":"7","article-title":"Infliximab in chronic ocular inflammation","volume":"43","author":"Baugham","year":"2005","journal-title":"Clin Pharm Therap"},{"key":"R57-12-20210206","first-page":"1362","article-title":"Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Beh\u00e7et's disease with refractory uveoretinitis","volume":"31","author":"Ohno","year":"2004","journal-title":"J Rheumatol"},{"key":"R58-12-20210206","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ajo.2004.04.066","article-title":"Infliximab for chronic cystoid macular edema associated with uveitis","volume":"138","author":"Markomichelakis","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R59-12-20210206","first-page":"181","article-title":"Successful treatment of long-standing neuro-Beh\u00e7et's disease with infliximab","volume":"32","author":"Sarwar","year":"2005","journal-title":"J Rheumatol"},{"key":"R60-12-20210206","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s10067-004-0944-1","article-title":"Transverse myelitis in a patient with Beh\u00e7et's disease: favorable outcome with a combination of interferon-\u03b1","volume":"24","author":"\u00c7alg\u00fcneri","year":"2005","journal-title":"Clin Rheumatol"},{"key":"R61-12-20210206","first-page":"1241","article-title":"Blind insight: eyeing antitumor necrosis factor treatment in uveitis associated with Beh\u00e7et's disease","volume":"31","author":"Rosenbaum","year":"2004","journal-title":"J Rheumatol"},{"key":"R62-12-20210206","first-page":"98","article-title":"Short-term trial of etanercept in Beh\u00e7et's disease: a double blind, placebo controlled study","volume":"32","author":"Melikoglu","year":"2005","journal-title":"J Rheumatol"},{"key":"R63-12-20210206","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/bjo.82.5.488","article-title":"Treatment of ocular symptoms of Beh\u00e7et's disease with interferon \u03b12a: a pilot study","volume":"82","author":"K\u00f6tter","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"R64-12-20210206","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1076\/ocii.8.4.293.6453","article-title":"Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Beh\u00e7et's disease","volume":"8","author":"Wechsler","year":"2000","journal-title":"Ocular Immunol Inflamm"},{"key":"R65-12-20210206","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.semarthrit.2003.09.005","article-title":"Differential efficacy of human recombinant interferon-\u03b12a on ocular and extraocular manifestations of Beh\u00e7et disease: results of an open 4-center trial","volume":"33","author":"K\u00f6tter","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"R66-12-20210206","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/rheumatology\/keh311","article-title":"Influence of human recombinant interferon-\u03b12a (rhIFN-\u03b12a) on altered lymphocyte subpopulations and monocytes in Beh\u00e7et's disease","volume":"43","author":"Treusch","year":"2004","journal-title":"Rheumatology"},{"key":"R67-12-20210206","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/rheumatology\/keg424","article-title":"Remission induction in Beh\u00e7et's disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH 1-H","volume":"42","author":"Lockwood","year":"2003","journal-title":"Rheumatology"},{"key":"R68-12-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.1000","article-title":"Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study","volume":"16","author":"Shimoyama","year":"2001","journal-title":"J Clin Apheresis"},{"key":"R69-12-20210206","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1381612033391928","article-title":"Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column","volume":"9","author":"Sawada","year":"2003","journal-title":"Curr Pharm Design"},{"key":"R70-12-20210206","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1007\/s00535-004-1464-0","article-title":"Suppression of interleukin-1\u03b2- and tumor necrosis factor-\u03b1-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis","volume":"39","author":"Andoh","year":"2004","journal-title":"J Gastroenterol"},{"key":"R71-12-20210206","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.jaad.2003.12.023","article-title":"Treatment of Beh\u00e7et's disease with granulocyte and monocyte adsorption apheresis","volume":"51","author":"Kanekura","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R72-12-20210206","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/archopht.123.2.267","article-title":"Therapeutic neutrophil apheresis in patients with ocular Beh\u00e7et disease","volume":"123","author":"Sonoda","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R73-12-20210206","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jca.20076","article-title":"Granulocytapheresis in patients with refractory ocular Beh\u00e7et's disease","volume":"21","author":"Namba","year":"2006","journal-title":"J Clin Apheresis"},{"key":"R74-12-20210206","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ajo.2004.04.064","article-title":"Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Beh\u00e7et's disease","volume":"138","author":"Kramer","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R75-12-20210206","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ajo.2004.02.053","article-title":"Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Beh\u00e7et's disease","volume":"138","author":"Karacorlu","year":"2004","journal-title":"Am J Ophthalmol"}],"container-title":["Current Opinion in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.icu.0000247411.59213.bb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:22:14Z","timestamp":1785943334000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00055735-200612000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.icu.0000247411.59213.bb","relation":{},"ISSN":["1040-8738"],"issn-type":[{"value":"1040-8738","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}